fedratinib
Showing 1 - 9 of 9
Assess the Safety of Fedratinib in Korean Myelofibrosis
Recruiting
- Primary Myelofibrosis
- +2 more
- Fedratinib
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Oct 3, 2023
Real World Evidence of Fedratinib Effectiveness in MF
Not yet recruiting
- Primary Myelofibrosis
- +2 more
- Fedratinib
- (no location specified)
May 22, 2023
Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,
Recruiting
- Acute Myeloid Leukemia
- +8 more
- Decitabine
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 18, 2022
Primary Myelofibrosis Trial in Japan (Fedratinib)
Recruiting
- Primary Myelofibrosis
- Fedratinib
-
Suwa, Nagano, Japan
- +25 more
Jan 18, 2023
IDH Mutation, IDH1 Mutation, IDH2 Gene Mutation Trial in Chicago (Ivosidenib, Enasidenib, Fedratinib)
Recruiting
- IDH Mutation
- +4 more
- Ivosidenib
- +2 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
Nov 12, 2021
Healthy Volunteers Trial in Dallas (Fedratinib, Rifampin, Efavirenz)
Completed
- Healthy Volunteers
- Fedratinib
- +2 more
-
Dallas, TexasCovance Clinical Research Unit Inc - Dallas
Aug 19, 2020
Healthy Volunteers Trial in Austin (Fedratinib, Digoxin, Rosuvastatin)
Completed
- Healthy Volunteers
- Fedratinib
- +3 more
-
Austin, TexasPPD Phase 1 Clinic
May 20, 2020